Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
21.00
-1.30 (-5.83%)
At close: Nov 10, 2026, 4:00 PM EST
20.95
-0.05 (-0.24%)
After-hours: Nov 10, 2026, 7:30 PM EST
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.45 billion as of November 10, 2026. It is the 8,132nd most valuable company in the world and the 1,997th biggest in the United States. Its market cap has increased by 89.82% in one year.
Market Cap
1.45B
Enterprise Value
755.65M
1-Year Change
89.82%
Global Rank
Country Rank
#1,997 United States
Category
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.45B, an increase of 121.61%. That is a compound annual growth rate of 16.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.45B | 3.39% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.64B |
| uniQure | 1.60B |
| Braveheart Bio | 1.59B |
| ADARx Pharmaceuticals | 1.55B |
| Rapport Therapeutics | 1.55B |
| Nuvation Bio | 1.54B |
| Structure Therapeutics | 1.53B |
| Ocular Therapeutix | 1.50B |